Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 67296-2321

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 67296-2321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container100mg100 (Container100mg100)

Container100mg100 (Container100mg100)
Label for Metoprolol Succinate Extended-Release Tablets, USP containing 100 mg strength. The label indicates 100 film-coated tablets, manufactured by Dr. Reddy's Laboratories Limited in India for Northstar Rx LLC, Memphis, TN. It includes storage instructions and a barcode with NDC 72603-144.*
FDA Label Image

Container200mg100 (Container200mg100)

Container200mg100 (Container200mg100)
Label for Metoprolol Succinate Extended-Release Tablets USP 200 mg, 100 tablets per package, manufactured by Dr. Reddy's Laboratories Limited and labeled for Northstar Rx LLC. The label includes storage instructions between 20°C to 25°C, a barcode, and product identification details. The tablets are film-coated and specified for Rx only use.*
FDA Label Image

Figure (Figure)

Figure (Figure)
A forest plot chart titled 'Results for Subgroups in MERIT-HF' displaying relative risk and 95% confidence intervals for metoprolol succinate extended-release tablets versus placebo. It includes three outcome categories: total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure. The chart compares various subgroups such as U.S., non-U.S., NYHA classifications, ejection fraction levels, ischemic etiology, sex, race, prior myocardial infarction, diabetes status, hypertension status, and heart rate.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Metoprolol succinate showing the molecular formula and bond arrangement of its active ingredient, Metoprolol succinate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.